Results 301 to 310 of about 5,504,431 (375)

LGBTQ+ Affirmative Care Training in Counselor Education: A Community‐Based Inquiry

open access: yesCounselor Education and Supervision, EarlyView.
ABSTRACT Counselor educators, counselors‐in‐training, and LGBTQ+ community members engaged in a community‐based qualitative inquiry exploring LGBTQ+ affirmative care education. Findings revealed counselor educators’ components and delivery of content, developmental implications for applying LGBTQ+ affirmative care, and gaps between education and LGBTQ+
Nancy E. Thacker Darrow   +2 more
wiley   +1 more source

ESG Messaging on Social Media and Cost of Capital: A Canadian Perspective

open access: yesCanadian Journal of Administrative Sciences / Revue Canadienne des Sciences de l'Administration, EarlyView.
ABSTRACT We examine whether environmental, social and governance (ESG) communications on social media decrease firms' cost of equity. Our results show that ESG messaging on social media does not appear to influence investors, which leads us to examine why.
Dhruv Baswal, Sean Cleary
wiley   +1 more source

Populations Addressed in Vaccines Approved via the European Medicines Agency

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Therapeutic and prophylactic agents require robust evidence before patient use. Randomized controlled trials are essential for evaluating safety and efficacy but often exclude specific populations that are also targets for the intervention. This study assessed which populations are included in vaccine registration studies and/or addressed in label ...
Débora D. Gräf   +3 more
wiley   +1 more source

Catastrophic health expenditure of Vietnamese patients with gallstone diseases - a case for health insurance policy revaluation. [PDF]

open access: yesClinicoecon Outcomes Res, 2019
Tran BX   +16 more
europepmc   +1 more source

Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
There is increasing attention on the clinical utility and value of pharmacogenetic (PGx) testing to individualize medication management. Most clinical practice guidelines from medical professional societies do not recommend routine PGx testing, with a few key exceptions.
James M. Stevenson   +4 more
wiley   +1 more source

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy